Invited commentary  by Naylor, A. Ross
4. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg
MR, et al. Analysis of pooled data from the randomized controlled trials
of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:
107-16.
5. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr, Rosenfeld
ME, et al. A definition of initial, fatty streak, and intermediate lesions of
atherosclerosis. A report from the committee on vascular lesions of the
council on arteriosclerosis, American Heart Association. Circulation
1994;89:2462-78.
6. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN,
et al. Atherosclerotic plaque progression and vulnerability to rupture:
angiogenesis as a source of intraplaque hemorrhage. Arterioscler
Thromb Vasc Biol 2005;25:2054-61.
7. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK,
et al. Intraplaque hemorrhage and progression of coronary atheroma.
New Engl J Med 2003;349:2316-25.
8. Murphy RE, Moody AR, Morgan PS, Martel AL, Delay GS, Allder S,
et al. Prevalence of complicated carotid atheroma as detected by mag-
netic resonance direct thrombus imaging in patients with suspected
carotid artery stenosis and previous acute cerebral ischemia. Circulation
2003;107:3053-8.
9. Cappendijk VC, Cleutjens KB, Heeneman S, Schurink GW, Welten RJ,
Kessels AG, et al. In vivo detection of hemorrhage in human atheroscle-
rotic plaques with magnetic resonance imaging. J Mag Reson Imaging
2004;20:105-10.
10. Moody AR, Murphy RE, Morgan PS, Martel AL, Delay GS, Allder S,
et al. Characterization of complicated carotid plaque with magnetic
resonance direct thrombus imaging in patients with cerebral ischemia.
Circulation 2003;107:3047-52.
11. Altaf N, MacSweeney ST, Gladman J, Auer DP. Carotid intraplaque
hemorrhage predicts recurrent symptoms in patients with high-grade
carotid stenosis. Stroke 2007;38:1633-5.
12. TakayaN, YuanC, Chu B, SaamT,Underhill H, Cai J, et al. Association
between carotid plaque characteristics and subsequent ischemic cere-
brovascular events: a prospective assessment with MRI-initial results.
Stroke 2006;37:818-23.
13. Altaf N, Beech A, Goode S, Gladman J, Moody AR, Auer D, Mac-
Sweeney S. Magnetic resonance imaging detected carotid intraplaque
hemorrhage predicts embolization during carotid endarterectomy.
J Vasc Surg 2007;46:31-6.
14. Sidhu PS, Allan PL. Ultrasound assessment of internal carotid artery
stenosis. Clinical Radiol 1997;52:654-8.
15. CAVATAS investigators. Endovascular versus surgical treatment in
patients with carotid stenosis in the carotid and vertebral artery trans-
luminal angioplasty study (CAVATAS): a randomized trial. Lancet
2001;357:1729-37.
16. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al.
Guidelines for prevention of stroke in patients with ischemic stroke or
transient ischemic attack: A statement for healthcare professionals from
the American Heart Association/American Stroke Association Council
on Stroke: cosponsored by the Council on Cardiovascular Radiology
and Intervention: the American Academy of Neurology affirms the
value of this guideline. Circulation 2006;113:e409-49.
17. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid
plaque. Stroke 2000;31:774-81.
18. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological
assessment of 526 symptomatic carotid plaques in relation to the nature
and timing of ischemic symptoms: the oxford plaque study. Circulation
2006;113:2320-8.
19. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, et al.
Presence of intraplaque hemorrhage stimulates progression of carotid
atherosclerotic plaques: a high-resolution magnetic resonance imaging
study. Circulation 2005;111:2768-75.
20. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL.
Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and
thrombotic components of human atherosclerosis in vivo. Circulation
1996;94:932-8.
Submitted Jun 22, 2007; accepted Sep 29, 2007.
INVITED COMMENTARY
A. Ross Naylor, MD, FRCS, Leicester, United Kingdom
One of the most enduringHoly Grails in carotid practice is the
search for a preoperative biomarker or imaging parameter that
accurately identifies the “high-risk for stroke” patient amongst a
myriad of “lower-risk” patients attending cerebrovascular clinics.
Unfortunately, every attempt has (thus far) failed, and it is inevi-
table that some observers will retain an interested but sceptical
wariness regarding the suggestion by Altaf et al that magnetic
resonance detection of intraplaque hemorrhage (MR-IPH) might
optimize selection for carotid endarterectomy (CEA) or carotid
artery angioplasty and stenting (CAS).
At first sight, the omens seem promising. The Altaf et al data
suggest that MR-IPH in symptomatic patients with mild/moder-
ate disease predicted an increased risk of recurrent ipsilateral events
during a median 28 months’ follow-up. These data are consistent
with earlier observations that MR-IPH correlated positively with
recurrent ipsilateral events in symptomatic patients with 70% to
99% stenoses awaiting CEA1 and an increased rate of particulate
embolization detected during CEA.2
So why do I retain doubts? I genuinely want this type of research
to succeed, as too many CEA/CAS procedures are performed in
otherwise very low-risk patients: seven of 10 symptomatic and nine of
10 asymptomatic interventions are (with hindsight) unnecessary.
However, I keep returning to the anomaly in this paper, which was
also present in an earlier study by Atlaf et al in patients with severe
carotid disease.1 Why is it that MR-IPH was only predictive of
recurrent events in the ipsilateral symptomatic artery and not in the
contralateral asymptomatic artery? In this study, 58% of contralateral
asymptomatic carotid arteries hadMR-IPH, yet noneof these patients
had a stroke during 28 months of follow-up. The authors acknowl-
edged this discrepancy, but did not offer an explanation other than
noting that coassociation with symptoms was important. Is it possible
that some of the “high signal” in these symptomatic patients repre-
sented fresh luminal thrombus?
So what are my take-home messages? Notwithstanding the
good omens, I need a little more convincing about whether
MR-IPH represents cause or effect in symptomatic and asymptom-
atic patients. Second, I would like to know about temporal changes
in MR-IPH: Is it a constant feature, or does it regress with time or
statin therapy? Third, is MR-IPH associated with increased proce-
dural risks after CAS? Finally, the anomaly regarding MR-IPH in
asymptomatic patients could simply reflect small numbers and
short follow-up. I hope that others—perhaps even the Transatlan-
tic Asymptomatic Carotid Intervention Trial (TACIT)3 with its
randomized medical arm—will undertake corroborative studies in
larger cohorts of patients. The importance of identifying a reliable
preoperative marker of increased stroke risk cannot be understated.
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